Sai Life Sciences Share Price
1608.00+0.00 (+0.47%)
+76.00% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
SAILIFENSE
Sai Life Sciences Share Price
1608.00+0.00 (+0.47%)
+76.00% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 18% | 24% | 22% | 29% |
| 26% | 42% | 227% | 105% |
| - | - | - | 76% |
| 10% | 7% | 12% | 15% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
AUROPHARMA
LUPIN
DRREDDY
MANKIND
SAILIFE
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,868.9 | ₹440398 Cr | 36.41 | 12.07 | 62.82 | ₹11479 Cr |
| 9,410.5 | ₹248664 Cr | 85.01 | 34.04 | 128.41 | ₹2568 Cr |
| 4,970 | ₹182738 Cr | 83.79 | 16.72 | 97.06 | ₹2163 Cr |
| 1,161 | ₹115012 Cr | 25.48 | 9.42 | 62.53 | ₹5040 Cr |
| 1,386.1 | ₹110794 Cr | 32.87 | 9.77 | 57.87 | ₹3879 Cr |
| 2,017.5 | ₹105645 Cr | 96.62 | 6.8 | 29.25 | ₹889 Cr |
| 1,713.4 | ₹99828 Cr | 26.89 | 17.95 | 96.84 | ₹3505 Cr |
| 2,124.5 | ₹98070 Cr | 17.74 | 30.95 | 154.36 | ₹5333 Cr |
| 1,198.3 | ₹97749 Cr | 30.34 | 5.32 | 63.99 | ₹4196 Cr |
| 2,437.8 | ₹95744 Cr | 46.87 | 13.75 | 71.08 | ₹1913 Cr |
| 1,604 | ₹34003 Cr | 94 | 3.45 | 25.27 | ₹349 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| ₹554 Cr | ₹602 Cr | ₹556 Cr | ₹537 Cr | ₹496 Cr | ₹580 Cr | ₹440 Cr | ₹396 Cr | ₹280 Cr | ₹439 Cr | ₹384 Cr |
| ₹4 Cr | ₹16 Cr | ₹8 Cr | ₹15 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹10 Cr | ₹8 Cr | ₹3 Cr | ₹11 Cr |
| ₹558 Cr | ₹618 Cr | ₹565 Cr | ₹553 Cr | ₹506 Cr | ₹589 Cr | ₹449 Cr | ₹406 Cr | ₹288 Cr | ₹443 Cr | ₹395 Cr |
| ₹452 Cr | ₹471 Cr | ₹413 Cr | ₹431 Cr | ₹413 Cr | ₹459 Cr | ₹354 Cr | ₹329 Cr | ₹285 Cr | ₹346 Cr | ₹319 Cr |
| ₹152 Cr | ₹192 Cr | ₹196 Cr | ₹161 Cr | ₹131 Cr | ₹167 Cr | ₹129 Cr | ₹112 Cr | ₹34 Cr | ₹128 Cr | ₹108 Cr |
| ₹8 Cr | ₹8 Cr | ₹10 Cr | ₹9 Cr | ₹12 Cr | ₹11 Cr | ₹23 Cr | ₹21 Cr | ₹21 Cr | ₹21 Cr | ₹23 Cr |
| ₹98 Cr | ₹139 Cr | ₹134 Cr | ₹112 Cr | ₹81 Cr | ₹119 Cr | ₹72 Cr | ₹55 Cr | -₹18 Cr | ₹76 Cr | ₹53 Cr |
| ₹73 Cr | ₹104 Cr | ₹100 Cr | ₹84 Cr | ₹60 Cr | ₹88 Cr | ₹54 Cr | ₹42 Cr | -₹13 Cr | ₹56 Cr | ₹40 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹21 Cr | ₹21 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹16 Cr | ₹16 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
| ₹4 Cr | ₹5 Cr | ₹11 Cr | ₹9 Cr | ₹9 Cr | ₹7 Cr | ₹6 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹2458 Cr | ₹2102 Cr | ₹946 Cr | ₹861 Cr | ₹852 Cr | ₹838 Cr | ₹772 Cr | ₹700 Cr | ₹348 Cr | ₹305 Cr | ₹260 Cr | ₹206 Cr | ₹183 Cr | ₹159 Cr | ₹144 Cr | ₹131 Cr |
| ₹2458 Cr | ₹2102 Cr | ₹946 Cr | ₹861 Cr | ₹852 Cr | ₹838 Cr | ₹772 Cr | ₹700 Cr | ₹348 Cr | ₹305 Cr | ₹260 Cr | ₹206 Cr | ₹183 Cr | ₹159 Cr | ₹144 Cr | ₹131 Cr |
| ₹2484 Cr | ₹2128 Cr | ₹975 Cr | ₹888 Cr | ₹879 Cr | ₹863 Cr | ₹794 Cr | ₹720 Cr | ₹367 Cr | ₹321 Cr | ₹274 Cr | ₹220 Cr | ₹196 Cr | ₹172 Cr | ₹157 Cr | ₹144 Cr |
| ₹21 Cr | ₹0 | ₹277 Cr | ₹261 Cr | ₹297 Cr | ₹246 Cr | ₹60 Cr | ₹77 Cr | ₹68 Cr | ₹70 Cr | ₹39 Cr | ₹51 Cr | ₹63 Cr | ₹42 Cr | ₹23 Cr | ₹65 Cr |
| ₹115 Cr | ₹97 Cr | ₹73 Cr | ₹54 Cr | ₹57 Cr | ₹61 Cr | ₹43 Cr | ₹33 Cr | ₹15 Cr | ₹3 Cr | ₹23 Cr | ₹23 Cr | ₹18 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr |
| ₹128 Cr | ₹165 Cr | ₹177 Cr | ₹200 Cr | ₹192 Cr | ₹29 Cr | ₹32 Cr | ₹38 Cr | ₹12 Cr | ₹9 Cr | ₹90 L | ₹0 | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹0 |
| ₹59 Cr | ₹60 Cr | ₹66 Cr | ₹17 Cr | ₹19 Cr | ₹19 Cr | ₹15 Cr | ₹12 Cr | ₹9 Cr | ₹7 Cr | ₹13 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹0 |
| ₹322 Cr | ₹322 Cr | ₹594 Cr | ₹532 Cr | ₹565 Cr | ₹356 Cr | ₹149 Cr | ₹160 Cr | ₹103 Cr | ₹89 Cr | ₹76 Cr | ₹77 Cr | ₹86 Cr | ₹57 Cr | ₹38 Cr | ₹74 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹285 Cr | ₹323 Cr | ₹138 Cr | ₹209 Cr | ₹199 Cr | ₹138 Cr | ₹143 Cr | ₹107 Cr | ₹95 Cr | ₹47 Cr | ₹61 Cr | ₹48 Cr | ₹49 Cr | ₹48 Cr | ₹25 Cr | ₹33 Cr |
| ₹407 Cr | ₹263 Cr | ₹219 Cr | ₹167 Cr | ₹103 Cr | ₹97 Cr | ₹93 Cr | ₹72 Cr | ₹49 Cr | ₹69 Cr | ₹53 Cr | ₹40 Cr | ₹41 Cr | ₹34 Cr | ₹30 Cr | ₹4 Cr |
| ₹70 Cr | ₹129 Cr | ₹374 Cr | ₹372 Cr | ₹404 Cr | ₹358 Cr | ₹222 Cr | ₹149 Cr | ₹149 Cr | ₹119 Cr | ₹96 Cr | ₹80 Cr | ₹77 Cr | ₹73 Cr | ₹51 Cr | ₹0 |
| ₹143 Cr | ₹45 Cr | ₹8 Cr | ₹11 Cr | ₹8 Cr | ₹6 Cr | ₹9 Cr | ₹7 Cr | ₹7 Cr | ₹4 Cr | ₹35 Cr | ₹4 Cr | ₹3 Cr | ₹5 Cr | ₹2 Cr | ₹5 Cr |
| ₹905 Cr | ₹759 Cr | ₹740 Cr | ₹759 Cr | ₹715 Cr | ₹599 Cr | ₹467 Cr | ₹336 Cr | ₹299 Cr | ₹238 Cr | ₹245 Cr | ₹171 Cr | ₹170 Cr | ₹160 Cr | ₹108 Cr | ₹41 Cr |
| ₹3710 Cr | ₹3209 Cr | ₹2309 Cr | ₹2179 Cr | ₹2159 Cr | ₹1817 Cr | ₹1410 Cr | ₹1215 Cr | ₹769 Cr | ₹648 Cr | ₹596 Cr | ₹468 Cr | ₹451 Cr | ₹388 Cr | ₹303 Cr | ₹260 Cr |
| ₹97 Cr | ₹58 Cr | ₹24 Cr | ₹16 Cr | ₹19 Cr | ₹14 Cr | ₹8 Cr | ₹8 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹38 L | ₹94 L | ₹0 |
| ₹95 Cr | ₹129 Cr | ₹710 Cr | ₹699 Cr | ₹751 Cr | ₹637 Cr | ₹304 Cr | ₹250 Cr | ₹235 Cr | ₹208 Cr | ₹155 Cr | ₹146 Cr | ₹151 Cr | ₹127 Cr | ₹85 Cr | ₹65 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹2607 Cr | ₹2116 Cr | ₹1679 Cr | ₹1418 Cr | ₹1260 Cr | ₹991 Cr | ₹810 Cr | ₹489 Cr | ₹355 Cr | ₹293 Cr | ₹315 Cr | ₹307 Cr | ₹286 Cr | ₹244 Cr | ₹210 Cr | ₹167 Cr |
| ₹792 Cr | ₹628 Cr | ₹500 Cr | ₹381 Cr | ₹288 Cr | ₹237 Cr | ₹169 Cr | ₹115 Cr | ₹48 Cr | ₹21 Cr | ₹112 Cr | ₹94 Cr | ₹74 Cr | ₹58 Cr | ₹45 Cr | ₹34 Cr |
| ₹1815 Cr | ₹1488 Cr | ₹1180 Cr | ₹1037 Cr | ₹972 Cr | ₹753 Cr | ₹641 Cr | ₹373 Cr | ₹307 Cr | ₹272 Cr | ₹203 Cr | ₹213 Cr | ₹212 Cr | ₹185 Cr | ₹165 Cr | ₹133 Cr |
| ₹270 Cr | ₹124 Cr | ₹107 Cr | ₹151 Cr | ₹189 Cr | ₹194 Cr | ₹91 Cr | ₹116 Cr | ₹14 Cr | ₹9 Cr | ₹8 Cr | ₹2 Cr | ₹4 Cr | ₹16 Cr | ₹4 Cr | ₹7 Cr |
| ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L |
| ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L |
| ₹91 Cr | ₹63 Cr | ₹74 Cr | ₹24 Cr | ₹50 Cr | ₹63 Cr | ₹66 Cr | ₹31 Cr | ₹21 Cr | ₹15 Cr | ₹48 Cr | ₹44 Cr | ₹50 Cr | ₹33 Cr | ₹22 Cr | ₹0 |
| ₹49 Cr | ₹73 L | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹17 L | ₹4 Cr | ₹8 Cr | ₹6 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹0 | ₹0 | ₹0 |
| ₹2228 Cr | ₹1678 Cr | ₹1364 Cr | ₹1215 Cr | ₹1213 Cr | ₹1014 Cr | ₹798 Cr | ₹525 Cr | ₹350 Cr | ₹302 Cr | ₹263 Cr | ₹260 Cr | ₹268 Cr | ₹234 Cr | ₹191 Cr | ₹140 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹47 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| ₹151 Cr | ₹119 Cr | ₹87 Cr | ₹140 Cr | ₹127 Cr | ₹76 Cr | ₹44 Cr | ₹44 Cr | ₹73 Cr | ₹44 Cr | ₹37 Cr | ₹38 Cr | ₹30 Cr | ₹29 Cr | ₹19 Cr | ₹22 Cr |
| ₹374 Cr | ₹355 Cr | ₹256 Cr | ₹284 Cr | ₹243 Cr | ₹206 Cr | ₹270 Cr | ₹234 Cr | ₹262 Cr | ₹230 Cr | ₹179 Cr | ₹122 Cr | ₹126 Cr | ₹83 Cr | ₹55 Cr | ₹46 Cr |
| ₹111 Cr | ₹464 Cr | ₹159 Cr | ₹86 Cr | ₹130 Cr | ₹76 Cr | ₹98 Cr | ₹250 Cr | ₹17 Cr | ₹15 Cr | ₹20 Cr | ₹2 Cr | ₹7 Cr | ₹17 Cr | ₹19 Cr | ₹19 Cr |
| ₹71 Cr | ₹59 Cr | ₹50 Cr | ₹52 Cr | ₹24 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹15 Cr | ₹9 Cr | ₹15 Cr | ₹3 Cr | ₹3 Cr | ₹24 L | ₹35 L | ₹0 |
| ₹728 Cr | ₹535 Cr | ₹392 Cr | ₹402 Cr | ₹421 Cr | ₹426 Cr | ₹181 Cr | ₹143 Cr | ₹53 Cr | ₹48 Cr | ₹84 Cr | ₹42 Cr | ₹16 Cr | ₹23 Cr | ₹18 Cr | ₹31 Cr |
| ₹1481 Cr | ₹1531 Cr | ₹945 Cr | ₹964 Cr | ₹945 Cr | ₹804 Cr | ₹613 Cr | ₹691 Cr | ₹420 Cr | ₹346 Cr | ₹333 Cr | ₹208 Cr | ₹184 Cr | ₹154 Cr | ₹112 Cr | ₹120 Cr |
| ₹577 Cr | ₹772 Cr | ₹205 Cr | ₹205 Cr | ₹231 Cr | ₹205 Cr | ₹146 Cr | ₹355 Cr | ₹120 Cr | ₹108 Cr | ₹88 Cr | ₹36 Cr | ₹14 Cr | -₹6 Cr | ₹4 Cr | ₹78 Cr |
| ₹3710 Cr | ₹3209 Cr | ₹2309 Cr | ₹2179 Cr | ₹2159 Cr | ₹1817 Cr | ₹1410 Cr | ₹1215 Cr | ₹769 Cr | ₹648 Cr | ₹596 Cr | ₹468 Cr | ₹451 Cr | ₹388 Cr | ₹303 Cr | ₹260 Cr |
| ₹117 | ₹102 | ₹546 | ₹498 | ₹495 | ₹491 | ₹481 | ₹438 | ₹256 | ₹228 | ₹196 | ₹165 | ₹148 | ₹131 | ₹120 | ₹110 |
| ₹117 | ₹102 | ₹55 | ₹50 | ₹50 | ₹49 | ₹48 | ₹44 | ₹26 | ₹23 | ₹20 | ₹17 | ₹15 | ₹13 | ₹12 | ₹11 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹466 Cr | ₹228 Cr | ₹109 Cr | ₹16 Cr | ₹10 Cr | ₹82 Cr | ₹109 Cr | ₹113 Cr | ₹63 Cr | ₹64 Cr | ₹50 Cr | ₹31 Cr | ₹33 Cr | ₹14 Cr | ₹18 Cr | ₹25 Cr |
| ₹156 Cr | ₹239 Cr | ₹206 Cr | ₹172 Cr | ₹128 Cr | ₹98 Cr | ₹73 Cr | ₹68 Cr | ₹49 Cr | ₹27 Cr | ₹30 Cr | ₹32 Cr | ₹26 Cr | ₹17 Cr | ₹19 Cr | ₹14 Cr |
| -₹74 Cr | -₹131 Cr | -₹38 Cr | ₹35 Cr | -₹25 Cr | -₹201 Cr | -₹47 Cr | -₹24 Cr | -₹52 Cr | -₹53 Cr | -₹40 Cr | -₹26 Cr | -₹45 Cr | -₹24 Cr | -₹7 Cr | -₹18 Cr |
| ₹548 Cr | ₹336 Cr | ₹277 Cr | ₹223 Cr | ₹113 Cr | -₹21 Cr | ₹135 Cr | ₹157 Cr | ₹60 Cr | ₹38 Cr | ₹40 Cr | ₹36 Cr | ₹15 Cr | ₹6 Cr | ₹30 Cr | ₹21 Cr |
| ₹509 Cr | ₹314 Cr | ₹263 Cr | ₹219 Cr | ₹105 Cr | -₹36 Cr | ₹116 Cr | ₹129 Cr | ₹49 Cr | ₹19 Cr | ₹30 Cr | ₹31 Cr | ₹7 Cr | ₹5 Cr | ₹26 Cr | ₹17 Cr |
| -₹395 Cr | -₹537 Cr | -₹192 Cr | -₹102 Cr | -₹104 Cr | -₹260 Cr | -₹262 Cr | -₹158 Cr | -₹62 Cr | -₹69 Cr | -₹30 Cr | -₹18 Cr | -₹12 Cr | -₹33 Cr | -₹39 Cr | -₹20 Cr |
| -₹124 Cr | ₹301 Cr | -₹95 Cr | -₹201 Cr | ₹72 Cr | ₹295 Cr | -₹4 Cr | ₹268 Cr | ₹12 Cr | ₹44 Cr | ₹15 Cr | -₹18 Cr | ₹9 Cr | ₹31 Cr | ₹13 Cr | ₹1 Cr |
| -₹10 Cr | ₹79 Cr | -₹25 Cr | -₹83 Cr | ₹73 Cr | -₹78 L | -₹150 Cr | ₹239 Cr | -₹77 L | -₹6 Cr | ₹15 Cr | -₹5 Cr | ₹4 Cr | ₹3 Cr | ₹11 L | -₹2 Cr |
| ₹91 Cr | ₹12 Cr | ₹36 Cr | ₹116 Cr | ₹41 Cr | ₹41 Cr | ₹192 Cr | -₹47 Cr | ₹10 Cr | ₹16 Cr | ₹68 L | ₹6 Cr | ₹4 Cr | ₹52 L | ₹41 L | ₹20 Cr |
| ₹82 L | ₹28 L | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹0 | ₹10,000 | -₹19,000 | ₹6 L | -₹6 L | -₹1 L | ₹1,913 | -₹2 L | -₹4 L | ₹0 | ₹0 |
| ₹82 Cr | ₹91 Cr | ₹12 Cr | ₹36 Cr | ₹116 Cr | ₹41 Cr | ₹41 Cr | ₹192 Cr | ₹9 Cr | ₹10 Cr | ₹16 Cr | ₹68 L | ₹7 Cr | ₹4 Cr | ₹52 L | ₹19 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Sai Life Sciences Share Price
1608.00+0.00 (+0.47%)
+76.00% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 2 out of 9 oscillators
RSI
62.39Buy
STOCH %K
62.43Neutral
MACD Level(12,26)
46.37Buy
Ultimate Oscillator
41.99Sell
Aroon Oscillator
68.00Buy
BOP
-0.20Sell
CCI
77.71Neutral
Williams %R
-37.57Neutral
Momentum
148.30Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 9
Bearish signals: 0 out of 9 moving averages
EMA 9
1578.42Buy
SMA 9
1592.60Buy
EMA 21
1542.33Buy
SMA 21
1543.80Buy
EMA 50
1447.56Buy
SMA 50
1429.85Buy
EMA 200
1176.52Buy
SMA 200
1115.01Buy
WMA 20
1573.32Buy
Pivot
Pivot
Classic
Resistance 5
1842.63
Resistance 4
1779.03
Resistance 3
1715.43
Resistance 2
1651.83
Resistance 1
1626.17
Pivot
1588.23
Support 1
1562.57
Support 2
1524.63
Support 3
1461.03
Support 4
1397.43
Support 5
1333.83
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Sai Life Sciences Share Price
1608.00+0.00 (+0.47%)
+76.00% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 34.53% | 34.61% | 34.70% | 34.94% | 35.15% | 35.17% |
| 19.65% | 21.17% | 21.41% | 22.50% | 14.57% | 12.36% |
| 3.24% | 3.74% | 3.84% | 3.75% | 2.91% | 1.72% |
| 29.47% | 27.80% | 27.57% | 26.17% | 18.73% | 11.54% |
| 13.11% | 12.68% | 12.48% | 12.64% | 28.64% | 39.21% |
Bulk & block deals
Name
Morgan Stanley Asia Singapore Pte
Goldman Sachs Bank Europe Se - Odi
Goldman Sachs Bank Europe Se - Odi
Goldman Sachs (Singapore) Pte - Odi
Goldman Sachs Bank Europe Se - Odi
Goldman Sachs (Singapore) Pte - Odi
Goldman Sachs Bank Europe Se - Odi
Goldman Sachs (Singapore) Pte - Odi
Societe Generale
Goldman Sachs (Singapore) Pte
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 30 Mar 2026 | Purchase | 80.92 Cr | ₹1,015.40 | 7.97 L | Block | 0.375164 | NSE |
| 30 Mar 2026 | Sell | 80.92 Cr | ₹1,015.40 | 7.97 L | Block | 0.375164 | NSE |
| 18 Sep 2025 | Purchase | 54.11 Cr | ₹898.50 | 6.02 L | Block | 0.283491 | NSE |
| 18 Sep 2025 | Sell | 54.11 Cr | ₹898.50 | 6.02 L | Block | 0.283491 | NSE |
| 17 Sep 2025 | Purchase | 35.38 Cr | ₹881.35 | 4.01 L | Block | 0.188994 | NSE |
| 17 Sep 2025 | Sell | 35.38 Cr | ₹881.35 | 4.01 L | Block | 0.188994 | NSE |
| 16 Sep 2025 | Purchase | 24.27 Cr | ₹882 | 2.75 L | Block | 0.129558 | NSE |
| 16 Sep 2025 | Sell | 24.27 Cr | ₹882 | 2.75 L | Block | 0.129558 | NSE |
| 26 Aug 2025 | Purchase | 122.54 Cr | ₹871 | 14.07 L | Bulk | 0.662336 | NSE |
| 26 Aug 2025 | Purchase | 96.16 Cr | ₹871.05 | 11.04 L | Bulk | 0.519733 | NSE |
Insider trading & SAST
Client name
Invesco Mutual Fund
Tpg Asia Vii Sf Pte Ltd
Invesco Mutual Fund
Tpg Asia Vii Sf Pte Ltd
Tuneer Ghosh
Tuneer Ghosh
Rajesh V Naik (Revised)
Supratim Halder (Revised)
Alagappan Subramanian
Sriram Gopalakrishnan (Revised)
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Oct 2025 | Other | Acquisition | 0.06 | 7.27 | 0 | — | 1.44 L | 13 Oct 2025 | Market | 1,52,70,648 | SAST | 29(2) | — |
| 29 Sep 2025 | Other | Disposal | 14.72 | — | 0 | — | 3.07 Cr | 26 Aug 2025 | Market | — | SAST | 29(2) | — |
| 24 Jul 2025 | Other | Acquisition | 0.26 | 5.24 | 0 | — | 5.50 L | 14 Jul 2025 | Market | 1,09,41,723 | SAST | 29(1) | — |
| 12 Jul 2025 | Other | Disposal | 10 | 14.73 | 0 | — | 2.08 Cr | 20 Jun 2025 | Market | 3,07,06,833 | SAST | 29(2) | — |
| 26 Feb 2025 | Designated Person | Disposal | 0.034179 | 0.24 | 5.07 Cr | ₹713.07 | 71.12 K | 21 Feb 2025 | Market Sale | 5,03,884 | Insider Trading | — | Equity Shares |
| 26 Feb 2025 | Designated Person | Disposal | 0.034179 | 0.24 | 711.16 | ₹0.01 | 71.12 K | 21 Feb 2025 | Market Sale | 5,03,884 | Insider Trading | — | Equity Shares |
| 02 Jan 2025 | Designated Person | Disposal | 0.072119 | 0 | 10.95 Cr | ₹730 | 1.50 L | 18 Dec 2024 - 20 Dec 2024 | Market Sale | 0 | Insider Trading | — | Equity Shares |
| 02 Jan 2025 | Designated Person | Disposal | 0.000962 | 0 | 14.81 L | ₹740.69 | 2 K | 23 Dec 2024 - 30 Dec 2024 | Market Sale | 8,000 | Insider Trading | — | Equity Shares |
| 27 Dec 2024 | Designated Person | Disposal | 0.000962 | 0 | 14.35 L | ₹717.50 | 2 K | 23 Dec 2024 - 24 Dec 2024 | Market Sale | 4,000 | Insider Trading | — | Equity Shares |
| 26 Dec 2024 | Designated Person | Disposal | 0.072119 | 0 | 10.98 Cr | ₹732.05 | 1.50 L | 19 Dec 2024 - 20 Dec 2024 | Market Sale | 0 | Insider Trading | — | Equity Shares |
Sai Life Sciences Share Price
1608.00+0.00 (+0.47%)
+76.00% past 1 Year
Sai Life Sciences is a fully integrated, science-led contract research, development, and manufacturing organization (CRDMO) focused on small molecule new chemical entities (NCEs). It serves global pharmaceutical and biotechnology companies
Corporate Actions
Date
Type
Details
Company details
Sai Life Sciences Share Price
1608.00+0.00 (+0.47%)
+76.00% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Sai Life Sciences Share Price
1608.00+0.00 (+0.47%)
+76.00% past 1 Year
News
Sai Life Sciences reports higher Q1 EBITDA and improved margin
Equity
SAILIFE
Sai Life Sciences informs about earnings call transcript
Equity
SAILIFE
Sai Life Sciences reports 18% rise in Q4 consolidated net profit
Equity
SAILIFE
Sai Life Sciences reports Profit after tax of 102.53 Crores, in the March 2026 quarter
Equity
SAILIFE
Sai Life Sciences Becomes First Indian CDMO to Operate Facility Solely on Renewable Energy
Equity
SAILIFE
Sai Life Sciences informs about earnings conference call
Equity
SAILIFE
Sai Life Sciences informs about disclosure
Equity
SAILIFE
Sai Life Sciences informs about disclosure
Equity
SAILIFE
Morgan Stanley Maintains Overweight on Sai Life Sciences, Raises Target to Rs 1,160.
Equity
SAILIFE
Jefferies Issues Buy Rating on Sai Life Sciences with Rs 1300 Target Price.
Equity
SAILIFE
Sai Life Sciences informs about updates
Equity
SAILIFE
Jefferies Raises Sai Life Sciences Target to Rs 1,300, Reiterates Buy Rating
Equity
SAILIFE
Sai Life Sciences informs about analyst meet
Equity
SAILIFE
Sai Life Sciences informs about allotment of equity shares under ESOP
Equity
SAILIFE
Sai Life Sciences informs about allotment under ESOP
Equity
SAILIFE
Sai Life Sciences shines as its consolidated net profit jumps 86% in Q3
Equity
SAILIFE
Sai Life Sciences’ consolidated net profit jumps 86% in Q3
Equity
SAILIFE
Sai Life Sciences Q3 EBITDA Rises to Rs 190 Crores, Margin Expands to 33.76% YoY.
Equity
SAILIFE
Sai Life Sciences Q3FY26 Results: Revenue Up 28% YoY to Rs 5,492 Mn, Net Profit Surges 91% to Rs 976 Mn.
Equity
SAILIFE
Sai Life Sciences reports Profit after tax of 97.63 Crores, in the December 2025 quarter
Equity
SAILIFE